We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.72B
AUM Growth
+$403M
Cap. Flow
+$53M
Cap. Flow %
0.93%
Top 10 Hldgs %
15.98%
Holding
769
New
66
Increased
305
Reduced
281
Closed
46

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$44.4M
2
PG icon
Procter & Gamble
PG
+$30.3M
3
BIDU icon
Baidu
BIDU
+$26.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$22.2M
5
LLY icon
Eli Lilly
LLY
+$22.1M

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$30.7M
2
SPLS
Staples Inc
SPLS
+$26.4M
3
MSI icon
Motorola Solutions
MSI
+$25.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.7M
5
AMGN icon
Amgen
AMGN
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 27.14%
2 Technology 13.76%
3 Financials 13.55%
4 Consumer Discretionary 9.45%
5 Communication Services 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MFC icon
351
Manulife Financial
MFC
$72.6B
$3.21M 0.06%
158,488
+2,514
+2% +$50K
RARE icon
352
Ultragenyx Pharmaceutical
RARE
$2.65B
$3.2M 0.06%
60,000
– –
ECL icon
353
Ecolab
ECL
$75.6B
$3.19M 0.06%
24,812
+2,366
+11% +$311K
GHDX
354
DELISTED
Genomic Health, Inc.
GHDX
$3.18M 0.06%
99,000
– –
BSX icon
355
Boston Scientific
BSX
$65.8B
$3.13M 0.05%
107,466
+8,598
+9% +$237K
ENB icon
356
Enbridge
ENB
$124B
$3.1M 0.05%
74,370
+8,486
+13% +$345K
GBT
357
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.01M 0.05%
97,000
+14,000
+17% +$394K
CTMX icon
358
CytomX Therapeutics
CTMX
$705M
$3M 0.05%
165,000
-30,000
-15% -$468K
NTRS icon
359
Northern Trust
NTRS
$22.2B
$2.98M 0.05%
32,430
-16,462
-34% -$1.49M
CTSH icon
360
Cognizant
CTSH
$21.5B
$2.98M 0.05%
41,050
+1,686
+4% +$118K
FISV
361
Fiserv Inc
FISV
$27.2B
$2.98M 0.05%
46,150
+5,762
+14% +$358K
GWPH
362
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.94M 0.05%
29,000
+5,000
+21% +$535K
AKAO
363
DELISTED
Achaogen Inc
AKAO
$2.91M 0.05%
182,555
-18,000
-9% -$343K
ICE icon
364
Intercontinental Exchange
ICE
$82.4B
$2.91M 0.05%
42,325
+3,107
+8% +$205K
ACAD icon
365
Acadia Pharmaceuticals
ACAD
$4.25B
$2.9M 0.05%
77,000
-50,000
-39% -$1.63M
RVTY icon
366
Revvity
RVTY
$12.3B
$2.9M 0.05%
42,000
– –
AERI
367
DELISTED
Aerie Pharmaceuticals
AERI
$2.87M 0.05%
59,000
+19,000
+48% +$1.04M
MOS icon
368
The Mosaic Company
MOS
$7.09B
$2.83M 0.05%
130,850
-156,243
-54% -$3.38M
AME icon
369
Ametek
AME
$55.5B
$2.81M 0.05%
42,548
+30,368
+249% +$1.92M
ODP
370
DELISTED
ODP
ODP
$2.81M 0.05%
61,872
– –
GIS icon
371
General Mills
GIS
$19.2B
$2.81M 0.05%
54,239
-14,767
-21% -$809K
TXMD icon
372
TherapeuticsMD
TXMD
$23.8M
$2.8M 0.05%
10,600
+1,000
+10% +$289K
ITCI
373
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.79M 0.05%
177,000
+22,000
+14% +$323K
HALO icon
374
Halozyme
HALO
$9.72B
$2.76M 0.05%
159,000
-83,000
-34% -$1.12M
VFC icon
375
VF Corp
VFC
$6.68B
$2.76M 0.05%
46,100
-11,804
-20% -$681K
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2017 Portfolio in Review

As of Q3 2017, Candriam SCA held 769 positions worth $5.72B, up 7.6% from $5.32B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q3 2017 filing shows 66 new, 305 increased, 281 reduced and 46 closed positions. Its largest new stake was Alaska Air: 139,079 shares worth $10.6M. The largest sale was GE Aerospace, an estimated $30.7M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2017 buy was Alaska Air: 139,079 shares worth $10.6M.
  • Candriam SCA added most to Microsoft in Q3 2017, an estimated $44.4M increase.
  • Candriam SCA's biggest Q3 2017 reduction was GE Aerospace, cutting an estimated $30.7M.
  • Candriam SCA fully exited Staples Inc in Q3 2017, selling an estimated $26.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.72B portfolio in Q3 2017.
  • Candriam SCA opened 66 new positions and closed 46 in Q3 2017.
  • Candriam SCA's portfolio value rose 7.6% quarter-over-quarter to $5.72B.

Based on Candriam SCA's 13F filing for Q3 2017, filed 3 Nov 2017.